St. Joseph Mercy Hospital

Last updated
St. Joseph Mercy Hospital
St. Joseph Mercy Hospital
Guyana location map.svg
Red pog.svg
Shown in Guyana
Location Georgetown, Guyana
Coordinates 6°49′21″N58°09′37″W / 6.822472°N 58.160283°W / 6.822472; -58.160283 Coordinates: 6°49′21″N58°09′37″W / 6.822472°N 58.160283°W / 6.822472; -58.160283
Funding Government/Charity
Type Non-profit
Beds70 [1]
Lists Hospitals in Guyana

St. Joseph Mercy Hospital is a Catholic non profit hospital.It is Located on Parade Street, Kingstown in Georgetown, Guyana. It was established by the members of the Sword of the Spirit movement and was officially opened in 1945. [2] The hospital includes a School of Nursing. The oldest wing of the hospital burnt down on Monday, May 10, 2010 at 7 am. [3] In 2020, the hospital opened a specialized COVID-19 treatment ward. [4]

Related Research Articles

USNS <i>Mercy</i> (T-AH-19) Hospital ship of the United States Navy

USNS Mercy (T-AH-19) is the lead ship of her class of hospital ships in non-commissioned service with the United States Navy. Her sister ship is USNS Comfort (T-AH-20). She is the third US Navy ship to be named for the virtue mercy. In accordance with the Geneva Conventions, Mercy and her crew do not carry any offensive weapons, though defensive weapons are available.

Suddie Village in Pomeroon-Supenaam, Guyana

Suddie is a community in the Pomeroon-Supenaam region of Guyana, located on the Atlantic Ocean, 1 mile north of Onderneeming.

Mercy (healthcare organization)

Mercy Health is a not-for-profit Catholic health care organization founded in 1871 by Sisters of Mercy. It is located in the Midwestern United States with headquarters within Greater St. Louis in the western St. Louis County, Missouri suburb of Chesterfield. Mercy is the fifth largest Catholic health care system in the United States and named one of the top five large U.S. health systems in 2018 by Truven.

Remdesivir Antiviral drug

Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID-19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in around 50 countries. Updated guidelines from the World Health Organization in November 2020 include a conditional recommendation against the use of remdesivir for the treatment of COVID-19.

COVID-19 pandemic in Guyana Ongoing COVID-19 viral pandemic in Guyana

The COVID-19 pandemic in Guyana is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Guyana on 11 March 2020. The first case was a woman who travelled from New York, a 52-year-old woman suffering from underlying health conditions, including diabetes and hypertension. The woman died at the Georgetown Public Hospital.

COVID-19 pandemic in Suriname Ongoing COVID-19 viral pandemic in Suriname

The COVID-19 pandemic in Suriname is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Suriname on 13 March 2020. The case was a person who travelled from the Netherlands the previous week. On 3 April 2020, one person died. On 3 May 2020, all nine cases had recovered. On 18 May, an eleventh case was identified.

COVID-19 drug development Preventative and therapeutic medications for COVID-19 infection

COVID‑19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus disease 2019 (COVID‑19). From early 2020 through 2021, several hundred drug companies, biotechnology firms, university research groups, and health organizations were developing therapeutic candidates for COVID‑19 disease in various stages of preclinical or clinical research, with 411 potential COVID-19 drugs in clinical trials, as of March 2021.

NHS Nightingale Hospital London Temporary NHS COVID-19 hospital set up in ExCeL London

The NHS Nightingale Hospital London is the first of the NHS Nightingale Hospitals: temporary hospitals set up by NHS England for the COVID-19 pandemic. It is housed in the ExCeL London convention centre in East London, and has an initial capacity for 500 patients, with potential for 4,000. The hospital was rapidly planned and constructed, being formally opened on 3 April and receiving its first patients on 7 April 2020.

NHS Nightingale Hospital Birmingham Temporary NHS COVID-19 hospital set up in NEC Birmingham

The NHS Nightingale Hospital Birmingham is the second of the temporary NHS Nightingale Hospitals set up by NHS England to help to deal with the COVID-19 pandemic. It was constructed inside the National Exhibition Centre, Solihull, and opened on 16 April 2020.

NHS Louisa Jordan Hospital Emergency critical care hospital created in 2020 to deal with the COVID-19 pandemic

The NHS Louisa Jordan is a temporary emergency critical care hospital created to deal with the COVID-19 pandemic in Scotland. It is located within the SEC Centre in Glasgow.

Hospital ships designated for the COVID-19 pandemic

In connection with the COVID-19 pandemic in the United States, the U.S. Navy's two Mercy-class hospital ships have been deployed— USNS Mercy to the Port of Los Angeles and Comfort to New York Harbor. The Indonesian Navy hospital ship KRI Dr Soeharso was deployed to transport crew members from the infected cruise ships World Dream and Diamond Princess back to Indonesia in February–March 2020.

NHS Nightingale Hospital Yorkshire and the Humber Temporary NHS COVID-19 hospital set up in Harrogate Convention Centre

The NHS Nightingale Hospital Yorkshire and the Humber is one of the temporary NHS Nightingale Hospitals set up by NHS England in 2020 to help to deal with the COVID-19 pandemic. The hospital was constructed inside the Harrogate Convention Centre, Harrogate, and from 4 June 2020 was repurposed as a radiology diagnostic clinic.

RECOVERY Trial Test of existing medicines on COVID-19

The Randomised Evaluation of COVID-19 Therapy is a large-enrollment clinical trial of possible treatments for people in the United Kingdom admitted to hospital with severe COVID-19 infection. The trial was later expanded to Indonesia, Nepal and Vietnam. The trial has tested ten interventions on adults: eight repurposed drugs, one newly developed drug and convalescent plasma.

Events in the year 2020 in Guyana.

COVID-19 pandemic in Kuala Lumpur, Malaysia started when a Chinese male national from Wuhan in the province of Hubei was tested positive on 3 February 2020. As of 10 July, Kuala Lumpur confirmed 2,445 cases and 18 fatalities.

Kandakadu Treatment and Rehabilitation Centre previously known as the Kandakadu Drug Rehabilitation Centre is a rehabilitation center located in the Welikanda, Polonnaruwa District, North Western Province in Sri Lanka. It is currently operated by the Bureau of the Commissioner General of Rehabilitation under the Ministry of Justice. The rehabilitation centre is currently used to treat drug addicts and COVID-19 patients along with Senapura Rehabilitation Center.

Long COVID purported long-term symptoms of COVID-19

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection, post-acute sequelae of COVID-19 (PASC), chronic COVID syndrome (CCS) and long-haul COVID, is a condition characterized by long-term sequelae—persisting after the typical convalescence period—of coronavirus disease 2019 (COVID-19). Long covid can affect nearly every organ system with sequelae including respiratory system disorders, nervous system and neurocognitive disorders, mental health disorders, metabolic disorders, cardiovascular disorders, gastrointestinal disorders, malaise, fatigue, musculoskeletal pain, and anemia. A wide range of symptoms are commonly discussed, including fatigue, headaches, shortness of breath, anosmia, parosmia, muscle weakness, low fever and cognitive dysfunction.

Chloroquine and hydroxychloroquine are anti-malarial medications also used against some auto-immune diseases. Chloroquine, along with hydroxychloroquine, was an early failed experimental treatment for COVID-19. They are not effective for preventing infection.


  1. "Visiting Hours & Accommodation". Mercy Hospital. Retrieved 22 August 2020.
  2. "History". Sisters of Mercy. Retrieved 22 August 2020.
  3. "Fire ravages St Joseph Mercy Hospital". Stabroek News. Retrieved 22 August 2020.
  4. "St. Joseph Mercy Hospital launches $20M COVID-19 testing and treatment centre". iNews Guyana. Retrieved 22 August 2020.